Pharmacological Pain Management

Pharmacological Pain Management 

Opioids are an important part of pain management, but there is currently a well-described epidemic of opioid misuse and overdose. In 2015, for example, there were 33,091 deaths from opioid overdose in the U.S., about half of which involved prescription opioids (Rudd et al., 2016). About 2 million people in the U.S. have opioid use disorder, in other words an addiction (Schuchat et al., 2017). Clinicians must therefore carefully balance the need to treat moderate to severe pain in their patients with the risks of opioid addiction and both intentional and accidental overdose. To do this, it is important to carefully assess the nature and severity of a patient’s pain and determine how much functional disability is involved. Reasonable goals for pain relief need to be set and a careful consideration of non-opioid interventions reviewed. If opioids are prescribed, they should be administered at the lowest possible dose for the shortest period of time needed to treat pain and with attention to risk factors for misuse or abuse. Patients with pain secondary to a malignant disease or who are in hospice care require special attention to their pain management needs.

$19.95

Hours: 1.00
REL-PI-0-P4PC30

Certificates

Certificates provided by accrediting body (0 Match)

Course Details

Course Code: REL-PI-0-P4PC30
Hours: 1
Type: Online Course
Content Expiration Date: 12/31/2021
Learning Objectives:
Verbalize the definition and assessment of different types of pain.
Identify and apply non-pharmacological and non-opioid, first-line interventions for pain.
Prescribe opioids safely and effectively.
Differentiate and evaluate the risk factors and preventative measures for opioid misuse, abuse, and overdose.
Recognize the special pain management needs of patients with malignant disease and in hospice care.

Outline:
Section 1: Introduction A. About This Course B. Learning Objectives Section 2: How Pain is Defined A. Characteristics of Pain B. Review C. Summary Section 3: Pain Management A. Meet Edward B. Review C. First-Line Treatments for Pain D. Review E. Summary Section 4: When and How to Prescribe Opioids A. When to Prescribe B. Risks and Adverse Effects C. Special Considerations D. Review E. Summary Section 5: The Problem of Opioid Misuse, Abuse, Addiction, and Overdose A. Risk Factors and Assessments B. Misuse and Abuse C. Review D. Summary Section 6: Treating Pain in Patients with Cancer and Terminal Illness A. Pain Management in Cancer and Terminal Illness B. Review C. Summary Section 7: Conclusion A. Summary B. Course Contributors C. Resources D. References E. Congratulations! F. Exam G. BrainSparks

Staff Writer: Adam Roesner, BSN
Adam Roesner, BSN has been working with various quality measures optimization since 2013. His experience in program management in both clinical and performance measures allows a unique perspective on the challenge faced by healthcare systems today. Adam has presented trainings on HCAHPS programs for sales forces and executive leadership alike, and has managed various skin health and HCAHPS educational programs and bundles for acute, post-acute, and IDN facilities. Disclosure: Adam Roesner, BSN has declared that no conflict of interest, Relevant Financial Relationship or Relevant Non-Financial Relationship exists.
Instructor: Jack M. Gorman, MD

Jack M. Gorman, M.D. co-founded Critica Inc, a non-profit corporation, with his daughter, Dr. Sara Gorman, in 2016 and is its President and Chair. Critica is devoted to fighting science denial and promoting the acceptance of science in health and safety decision-making.

Before founding Critica, Dr. Gorman was Chief Scientific Officer and Senior Vice-President of both Comprehensive NeuroScience Inc and Care Management Technologies Inc. Dr. Gorman is co-editor of the textbooks Treatments that Work, now in its fourth edition, and Comprehensive Textbook of AIDS Psychiatry, now in its second edition, and author of the popular book The Essential Guide to Psychiatric Drugs, which appeared in its fourth edition in 2007. With his daughter, Dr. Sara Gorman, he wrote Denying to the Grave, on the reasons behind denial of scientific medical evidence, published by Oxford University Press in 2016. It has been discussed in media throughout the world. His newest book, Neuroscience at the Intersection of Mind and Brain, was published in 2018.

Disclosure: Jack M. Gorman, MD has declared that no conflict of interest, Relevant Financial Relationship or Relevant Non-Financial Relationship exists.
Target Audience:
The target audience for this course is: Entry level Physicians; Nurses; in the following settings: All Healthcare Settings.
Relias will be transparent in disclosing if any commercial support, sponsorship or co-providership is present prior to the learner completing the course.
Course Delivery Method and Format
Asynchronous/Online Distance Learning; please see certificate details for specifics on delivery format.
Relias has a grievance policy in place to facilitate reports of dissatisfaction. Relias will make every effort to resolve each grievance in a mutually satisfactory manner. In order to report a complaint or grievance please contact Relias.
If you require special accommodations to complete this module, please contact Relias Support by completing the web form (https://www.relias.com/help) or by using the chat functionality.
All courses offered by Relias, LLC are developed from a foundation of diversity, inclusiveness, and a multicultural perspective. Knowledge, values and awareness related to cultural competency are infused throughout the course content.
Reference herein to any specific commercial product, process, or service by trade name, trademark, service mark, manufacturer or otherwise does not constitute or imply any endorsement, recommendation, or favoring of, or affiliation with, Relias, LLC.
All characteristics and organizations referenced in the following training are fictional. Any resemblance to any actual organizations or persons living or dead, is purely coincidental.
To earn continuing education credit for this course you must achieve a passing score of 80% on the post-test and complete the course evaluation.
Accommodations
If you require special accommodations to complete this module, please contact Relias Customer Support here.